Recombinant Human IL-9 GMP Protein _ 90372ES
Rul over billedet for at zoome ind Klik på billedet for at zoome
Recombinant Human IL-9 GMP Protein _ 90372ES
Recombinant Human IL-9 GMP Protein _ 90372ES
IInterleukin-9 (IL-9) is primarily expressed by activated T cells. IL-9 exerts its biological effects by binding to its specific receptor, IL-9Rα. It promotes Th2-type immune responses and is involved in the pathogenesis of allergic diseases, such as asthma and atopic dermatitis. Furthermore, IL-9 supports the growth of helper T cells in an IL-2 and IL-4-independent manner, and promotes the proliferation of mast cells, erythroid progenitor cells, and other cell types. Components Name 90372ES10 90372ES50 90372ES80 Recombinant Human IL-9 GMP Protein 10 μg 50 μg 1 mg Performance Synonyms Interleukin-9, IL-9, Cytokine P40...

Frequently Bought Together

Recombinant Human IL-9 GMP Protein _ 90372ES

YeasenSKU: 90372ES10
Size: 10 μg
Pris:
$265.00
Lager:
På lager

IInterleukin-9 (IL-9) is primarily expressed by activated T cells. IL-9 exerts its biological effects by binding to its specific receptor, IL-9Rα. It promotes Th2-type immune responses and is involved in the pathogenesis of allergic diseases, such as asthma and atopic dermatitis. Furthermore, IL-9 supports the growth of helper T cells in an IL-2 and IL-4-independent manner, and promotes the proliferation of mast cells, erythroid progenitor cells, and other cell types.

Components

Name

90372ES10

90372ES50

90372ES80

Recombinant Human IL-9 GMP Protein

10 μg

50 μg

1 mg

Performance

Synonyms

Interleukin-9, IL-9, Cytokine P40

Source

Human IL-9 Protein is expressed from CHO Cells.

Sequence

Gln 19 - Ile 144

Molecular Weight

The protein has a calculated MW of 14.1 kDa. The protein migrates as 40 kDa±3 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

Accession

P15248

Biological Activity

The ED50 as determined by the dose-dependent stimulation of the proliferation of human M07e cells is ≤ 2.0 ng/ml.

Purity

＞95% as determined by SDS-PAGE.

Endotoxin

＜0.01 EU/μg protein as determined by LAL method.

Sterility

Negative.

Mycoplasma

Negative.

Vitro Virus

Negative.

Host Cell Protein

Less than 0.5 ng/μg when tested by ELISA.

Host Cell DNA

Less than 20 ng/mg when tested by qPCR.

Formulation

Lyophilized from 0.22μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Physical Appearance

Lyophilized Powder

Product Features

High Purity: >95%, minimizing the risk of immune responses caused by residual host cell proteins (HCPs) or DNA.

Ultra-Low Endotoxin: <10 EU/mg, reducing the risk of fever or inflammatory responses.

Batch-to-Batch Consistency: Ensures stability and reproducibility in cell culture.

Regulatory Compliance: Meets regulatory requirements for cell therapy products and supports IND applications.

Animal-Origin-Free: Free from animal viruses, pathogenic substances, and adventitious agent contamination, ensuring a high level of safety.

Figures

1. SDS- PAGE

Figure 1. Human IL-9 GMP Protein on SDS-PAGE under reduced condition. The purity is greater than 95%.

2.Cell Based Assay

Figure 2. The ED50 as determined by a cell proliferation assay using human M07e cells is less than 2.0 ng/mL.

Storage

This product should be stored at -25 ~ -15°C for 2 years. After reconstitution, store at -85 to -65°C. Valid for 3 months.

FAQ

Citations

Documents

Applications

Du kan også lide

Forespørgsel

FAQ

Produktet er kun til forskningsformål og er ikke beregnet til terapeutisk eller diagnostisk brug hos mennesker eller dyr. Produkter og indhold er beskyttet af patenter, varemærker og ophavsrettigheder ejet af Yeasen Biotechnology. Varemærkesymboler angiver oprindelseslandet, ikke nødvendigvis registrering i alle regioner.

Visse applikationer kan kræve yderligere tredjeparts intellektuelle ejendomsrettigheder.

Yeasen er dedikeret til etisk videnskab og mener, at vores forskning bør adressere kritiske spørgsmål og samtidig sikre sikkerhed og etiske standarder.